Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Primary Target Pathway Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
CAL-85-1 Cabozantinib
0.031623
VEGFR2/MET
RTK
1.0082 0.00016
CAL-85-1 Cabozantinib
0.1
VEGFR2/MET
RTK
1.0169 -0.00055
CAL-85-1 Cabozantinib
0.31623
VEGFR2/MET
RTK
0.8769 0.01425
CAL-85-1 Cabozantinib
1.0
VEGFR2/MET
RTK
0.9066 0.01994
CAL-85-1 Cabozantinib
3.1623
VEGFR2/MET
RTK
0.7204 0.02854
CAL-85-1 Cabozantinib
10.0
VEGFR2/MET
RTK
0.1728 0.17862
HCC1143 Abemaciclib
0.001
CDK4/6
Cell cycle
0.8938 -0.00404
HCC1143 Abemaciclib
0.0031623
CDK4/6
Cell cycle
0.9193 -0.00541
HCC1143 Abemaciclib
0.01
CDK4/6
Cell cycle
0.7388 -0.00534
HCC1143 Abemaciclib
0.031623
CDK4/6
Cell cycle
0.5957 -0.00172
HCC1143 Abemaciclib
0.1
CDK4/6
Cell cycle
0.4126 -0.00406
HCC1143 Abemaciclib
0.31623
CDK4/6
Cell cycle
0.2761 -0.00268
HCC1143 Abemaciclib
1.0
CDK4/6
Cell cycle
0.1854 0.00721
HCC1143 Abemaciclib
3.1623
CDK4/6
Cell cycle
0.1385 0.02744
HCC1143 Abemaciclib
10.0
CDK4/6
Cell cycle
-0.0787 0.12659
HCC1143 Palbociclib
0.00031623
CDK4/6
Cell cycle
0.9935 0.00177
HCC1143 Palbociclib
0.001
CDK4/6
Cell cycle
1.0079 0.00171
HCC1143 Palbociclib
0.0031623
CDK4/6
Cell cycle
1.0203 -0.00461
HCC1143 Palbociclib
0.01
CDK4/6
Cell cycle
0.9533 -0.00651
HCC1143 Palbociclib
0.031623
CDK4/6
Cell cycle
0.8032 -0.00537
HCC1143 Palbociclib
0.1
CDK4/6
Cell cycle
0.6432 -0.00358
HCC1143 Palbociclib
0.31623
CDK4/6
Cell cycle
0.4914 -0.00644
HCC1143 Palbociclib
1.0
CDK4/6
Cell cycle
0.4060 -0.00728
HCC1143 Palbociclib
3.1623
CDK4/6
Cell cycle
0.2820 0.00028
HCC1143 AZD7762
0.001
CHK1/2
Cell cycle
1.1696 -0.00494